Given Imaging's PillCam Colon device lands 510(k) clearance from the FDA.
Given Imaging (NSDQ:GIVN) said it won 510(k) clearance from the FDA for its PillCam Colon, a modified version of its PillCam device.
MassDevice.com looks at the internet chatter surrounding the medical device industry with some of most searched-for companies of the last month.
MassDevice.com looked at some of the most talked-about medical device companies, based on trends in U.S. Google searches for the last 30 days.
Buckle up, because in this video, the PillCam takes viewers for a ride on the GI tract.
The PillCam, made by Israel's Given Imaging (NSDQ:GIVN) was recently acquired by Covidien (NYSE:COV) for $864 million.
Covidien's Japanese branch receives Shonin approval from the Japanese Ministry of Health, Labor & Welfare for the company's Endo GIA Reinforced Reload with Tri-Staple technology.
Covidien (NYSE:COV) said its Japanese branch secured regulatory approval for its Endo GIA surgical staple system.
Covidien CFO Charles Dockendorff plans to retire at the end of 2014, leaving a vacancy in a role he's filled for 25 years.
Covidien (NYSE:COV) said it's searching for a new CFO after Charles Dockendorff announced his plans to retire from the company at the end of 2014.
Dockendorff has been with the company since 1989, serving in a variety of finance-related roles. He was named CFO of Covidien predecessor Tyco Healthcare in 1995, helping lead the company to $10 billion in sales in 2007.
Covidien beats Wall Street's Q1 expectations despite a 19% profit dip, and the company touts a patent infringement win against Johnson & Johnson subsidiary Ethicon Endo-Surgery.
Massachusetts medical device maker Covidien opens a Center of Innovation in China, planning 3 more centers this year in emerging markets.
True to its promises, Covidien (NYSE:COV) is making big strides in emerging markets, today announcing the opening of its 1st Center of Innovation in India.